Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease
Rated 5 out of 5 Anonymous (verified owner) Month three, on the 7.5mg dose now, and still having a great experience with Citizen Meds
Improved Metabolic Health Tirzepatide boosts metabolic markers, reducing blood sugar levels, cholesterol, and blood pressure, and decreasing inflammation markers
Researchers from Cleveland Clinic analyzed electronic health record data to identify adults with overweight or obesity who used semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro/Zepbound, Eli Lilly) from 2021 to 2024
Lumigan (bimatoprost ophthalmic solution) is an FDA-approved medication widely prescribed to lower IOP in glaucoma patients
Most Accurate Polygenic Risk Scoring We leverage cutting-edge algorithms and analyze a massive dataset of 2 million people to deliver the most precise assessment of your genetic health predispositions
![GLP-1 users, meet your new best friend! 🤝 📚 Studies show most US adults lack Vitamins A, C, D, E, K, calcium, and magnesium in their daily diet.[4] 🍽️ People who lose weight or use GLP-1 meds often](https://www.tiktok.com/api/img/?itemId=7549518624776523038&location=0&aid=1988)
,aspect=ignore)
